604 related articles for article (PubMed ID: 29266437)
21. Renal injury in neonates: use of "omics" for developing precision medicine in neonatology.
Joshi MS; Montgomery KA; Giannone PJ; Bauer JA; Hanna MH
Pediatr Res; 2017 Jan; 81(1-2):271-276. PubMed ID: 27723726
[TBL] [Abstract][Full Text] [Related]
22. Advances in molecular classification of renal neoplasms.
Yin-Goen Q; Dale J; Yang WL; Phan J; Moffitt R; Petros JA; Datta MW; Amin MB; Wang MD; Young AN
Histol Histopathol; 2006 Mar; 21(3):325-39. PubMed ID: 16372253
[TBL] [Abstract][Full Text] [Related]
23. An overview of renal cell cancer: pathology and genetics.
Moch H
Semin Cancer Biol; 2013 Feb; 23(1):3-9. PubMed ID: 22722066
[TBL] [Abstract][Full Text] [Related]
24. PanCancer insights from The Cancer Genome Atlas: the pathologist's perspective.
Cooper LA; Demicco EG; Saltz JH; Powell RT; Rao A; Lazar AJ
J Pathol; 2018 Apr; 244(5):512-524. PubMed ID: 29288495
[TBL] [Abstract][Full Text] [Related]
25. Genomics and epigenomics of renal cell carcinoma.
Maher ER
Semin Cancer Biol; 2013 Feb; 23(1):10-7. PubMed ID: 22750267
[TBL] [Abstract][Full Text] [Related]
26. Integrative analysis of protein-coding and non-coding RNAs identifies clinically relevant subtypes of clear cell renal cell carcinoma.
Li Z; Chen Y; Hu S; Zhang J; Wu J; Ren W; Shao N; Ying X
Oncotarget; 2016 Dec; 7(50):82671-82685. PubMed ID: 27705920
[TBL] [Abstract][Full Text] [Related]
27. Personalized Medicine: Genomics Trials in Oncology.
Hayes DF; Schott AF
Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
[TBL] [Abstract][Full Text] [Related]
28. Overcome tumor heterogeneity-imposed therapeutic barriers through convergent genomic biomarker discovery: A braided cancer river model of kidney cancer.
Hsieh JJ; Manley BJ; Khan N; Gao J; Carlo MI; Cheng EH
Semin Cell Dev Biol; 2017 Apr; 64():98-106. PubMed ID: 27615548
[TBL] [Abstract][Full Text] [Related]
29. Evolving classification of renal cell neoplasia.
Delahunt B; Velickovic M; Grebe SK
Expert Rev Anticancer Ther; 2001 Dec; 1(4):576-84. PubMed ID: 12113090
[TBL] [Abstract][Full Text] [Related]
30. Molecular biology of renal cell cancer and the identification of therapeutic targets.
Iliopoulos O
J Clin Oncol; 2006 Dec; 24(35):5593-600. PubMed ID: 17158545
[TBL] [Abstract][Full Text] [Related]
31. Pathology of renal cell carcinoma: an update.
Lopez-Beltran A; Cheng L; Vidal A; Scarpelli M; Kirkali Z; Blanca A; Montironi R
Anal Quant Cytopathol Histpathol; 2013 Apr; 35(2):61-76. PubMed ID: 23700715
[TBL] [Abstract][Full Text] [Related]
32. Renal cell carcinoma: new insights and challenges for a clinician scientist.
Shingarev R; Jaimes EA
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F145-F154. PubMed ID: 28381462
[TBL] [Abstract][Full Text] [Related]
33. Molecular Classification of Renal Cell Carcinoma and Its Implication in Future Clinical Practice.
Casuscelli J; Vano YA; Fridman WH; Hsieh JJ
Kidney Cancer; 2017 Jul; 1(1):3-13. PubMed ID: 30334000
[TBL] [Abstract][Full Text] [Related]
34. Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine.
Jose A; Kulkarni P; Thilakan J; Munisamy M; Malhotra AG; Singh J; Kumar A; Rangnekar VM; Arya N; Rao M
Mol Cancer; 2024 Mar; 23(1):50. PubMed ID: 38461268
[TBL] [Abstract][Full Text] [Related]
35. From bench to bedside: current and future applications of molecular profiling in renal cell carcinoma.
Arsanious A; Bjarnason GA; Yousef GM
Mol Cancer; 2009 Mar; 8():20. PubMed ID: 19291329
[TBL] [Abstract][Full Text] [Related]
36. Metastatic renal cell carcinoma: many treatment options, one patient.
Rini BI
J Clin Oncol; 2009 Jul; 27(19):3225-34. PubMed ID: 19470934
[TBL] [Abstract][Full Text] [Related]
37. Precision Medicine and Melanoma: Multi-Omics Approaches to Monitoring the Immunotherapy Response.
Valenti F; Falcone I; Ungania S; Desiderio F; Giacomini P; Bazzichetto C; Conciatori F; Gallo E; Cognetti F; Ciliberto G; Morrone A; Guerrisi A
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917181
[TBL] [Abstract][Full Text] [Related]
38. Current and future strategies in nonclear-cell metastatic renal cell carcinoma.
Albiges L; Escudier B
Curr Opin Urol; 2015 Sep; 25(5):367-73. PubMed ID: 26153638
[TBL] [Abstract][Full Text] [Related]
39. Genomics of renal cell cancer: the biology behind and the therapy ahead.
Jones J; Libermann TA
Clin Cancer Res; 2007 Jan; 13(2 Pt 2):685s-692s. PubMed ID: 17255294
[TBL] [Abstract][Full Text] [Related]
40. [Papillary renal cell carcinoma: morphological subtypes, clinical and histopathological considerations].
Henry N; Rouach Y; Nguyen K; Verkarre V; Mejean A; Timsit MO
Prog Urol; 2010 Jun; 20(6):393-401. PubMed ID: 20538202
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
